Cite

HARVARD Citation

    Miller, A. et al. (n.d.). 1293. Sulbactam-durlobactam is active against recent, multi-drug resistant Acinetobacter baumannii clinical isolates from the Middle East. Open forum infectious diseases. p. S662. [Online]. 
  
Back to record